| Primary |
| Osteoporosis |
45.9% |
| Product Used For Unknown Indication |
24.1% |
| Osteoporosis Prophylaxis |
8.1% |
| Osteopenia |
6.2% |
| Drug Use For Unknown Indication |
4.5% |
| Hypertension |
1.8% |
| Bone Disorder |
1.3% |
| Prophylaxis |
1.3% |
| Osteoporosis Postmenopausal |
1.0% |
| Rheumatoid Arthritis |
0.9% |
| Asthma |
0.8% |
| Bone Density Decreased |
0.6% |
| Osteoporotic Fracture |
0.6% |
| Atrial Fibrillation |
0.5% |
| Spinal Fracture |
0.5% |
| Insomnia |
0.4% |
| Osteoarthritis |
0.4% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Pain |
0.3% |
| Systemic Lupus Erythematosus |
0.3% |
|
| Femur Fracture |
39.1% |
| Stress Fracture |
11.3% |
| Bone Disorder |
7.4% |
| Low Turnover Osteopathy |
6.9% |
| Osteonecrosis Of Jaw |
4.4% |
| Osteonecrosis |
4.1% |
| Pain |
3.9% |
| Pain In Extremity |
3.4% |
| Fracture |
2.8% |
| Pathological Fracture |
2.8% |
| Myalgia |
2.2% |
| Impaired Healing |
1.6% |
| Arthralgia |
1.4% |
| Oesophagitis |
1.3% |
| Product Quality Issue |
1.3% |
| Vomiting |
1.3% |
| Pain In Jaw |
1.2% |
| Product Substitution Issue |
1.2% |
| Vision Blurred |
1.2% |
| Weight Decreased |
1.1% |
|
| Secondary |
| Osteoporosis |
48.4% |
| Osteopenia |
25.3% |
| Osteoporosis Prophylaxis |
7.5% |
| Hypertension |
3.2% |
| Rheumatoid Arthritis |
2.9% |
| Product Used For Unknown Indication |
2.3% |
| Hypothyroidism |
1.4% |
| Prophylaxis |
1.1% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hyperlipidaemia |
0.8% |
| Asthma |
0.8% |
| Hypersensitivity |
0.8% |
| Depression |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Osteoarthritis |
0.6% |
| Diabetes Mellitus |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Pain |
0.5% |
| Menopause |
0.5% |
| Back Pain |
0.5% |
|
| Femur Fracture |
20.2% |
| Low Turnover Osteopathy |
17.1% |
| Vitamin D Deficiency |
8.0% |
| Stress Fracture |
7.1% |
| Bone Disorder |
5.8% |
| Fracture |
5.3% |
| Osteoporosis |
5.2% |
| Wrist Fracture |
3.2% |
| Weight Decreased |
2.8% |
| Fall |
2.8% |
| Osteoarthritis |
2.6% |
| Urinary Tract Infection |
2.6% |
| Weight Increased |
2.4% |
| Pain |
2.3% |
| Anxiety |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Tooth Extraction |
2.1% |
| Osteonecrosis Of Jaw |
2.0% |
| Pain In Extremity |
2.0% |
| Tooth Disorder |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.8% |
| Rheumatoid Arthritis |
23.0% |
| Product Used For Unknown Indication |
17.2% |
| Osteoporosis |
8.8% |
| Hypertension |
5.3% |
| Prophylaxis |
4.5% |
| Pain |
2.3% |
| Insomnia |
1.4% |
| Asthma |
1.4% |
| Depression |
1.3% |
| Diabetes Mellitus |
1.2% |
| Vitamin Supplementation |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Osteoporosis Prophylaxis |
1.1% |
| Crohn's Disease |
1.0% |
| Constipation |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Bone Disorder |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Hypothyroidism |
0.8% |
|
| Vomiting |
11.0% |
| Pneumonia |
9.3% |
| Weight Decreased |
7.5% |
| Pyrexia |
6.7% |
| Urinary Tract Infection |
6.5% |
| Sepsis |
5.0% |
| Nausea |
4.8% |
| Rheumatoid Arthritis |
4.7% |
| Death |
4.6% |
| Pain |
4.5% |
| Weight Increased |
4.5% |
| Respiratory Failure |
4.0% |
| Drug Ineffective |
3.9% |
| Rash |
3.9% |
| Interstitial Lung Disease |
3.6% |
| White Blood Cell Count Decreased |
3.2% |
| Pruritus |
3.1% |
| Dyspnoea |
3.1% |
| Pulmonary Embolism |
3.1% |
| Malaise |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
65.1% |
| Parkinson's Disease |
9.6% |
| Hypertension |
4.8% |
| Convulsion |
3.6% |
| Osteopenia |
2.4% |
| Osteoporosis |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Thrombosis |
2.4% |
| Atrial Fibrillation |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Dementia |
1.2% |
| Epilepsy |
1.2% |
| Scan Myocardial Perfusion |
1.2% |
| Smoking Cessation Therapy |
1.2% |
|
| Prescribed Overdose |
23.1% |
| Phlebitis |
15.4% |
| Drug Level Decreased |
7.7% |
| Dysgeusia |
7.7% |
| Injection Site Pain |
7.7% |
| Parkinson's Disease |
7.7% |
| Stomatitis |
7.7% |
| Tremor |
7.7% |
| Vomiting |
7.7% |
| Weight Increased |
7.7% |
|
